#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukoencephalopathy Vaginal cancer B-cell lymphoma Small cell lung cancer recurrent Non-Hodgkin's lymphoma Myotonia Myelodysplastic syndrome Ventricular fibrillation Guillain-Barre syndrome Arrhythmogenic right ventricular dysplasia Hairy cell leukaemia Ureteric cancer Raynaud's phenomenon Cataract Li-Fraumeni syndrome More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa Acquired haemophilia – Treatment Gaucher’s disease type I – Life with Disease Haemophagocytic lymphohistiocytosis – Treatment Immunodeficiency congenital – Diagnostics Retinitis pigmentosa – Diagnostics Fabry’s disease – Basic Information Mucopolysaccharidosis I – Life with Disease Inclusion body myositis Epidermolysis bullosa – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inclisiran Sodium Isoleucine MALIC ACID Dolutegravir Sodium Lurasidone Acetylsalicylic Acid Ph. Eur. Sodium Iodide Valemetostat Tosilate ZUNIBERGENE ROCPARVOVEC Fampridine Vanglusagene Ensiparvovec Methylprednisolone Aceponate Tavapadon Padeliporfin Gemcitabine Hydrochloride Atogepant Lidocaine Sphingomyelin (Egg) Ketotifen Hydrogen Fumarate Fedratinib More therapies…

    Learn about Your Condition

    Herpes simplex meningitis Synovial sarcoma Gastrectomy Epileptic encephalopathy Mental disorder Mucopolysaccharidosis II Encephalitis autoimmune Angiosarcoma recurrent Cardiac sarcoidosis Carcinoid tumour pulmonary Thromboembolectomy Pemphigoid Primary adrenal insufficiency Metastases to peritoneum Retinal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Long-Term Effects of Oral and Transdermal Estradiol Therapy in Women with Turner Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Turner’s syndrome
    Investigated Drugs:
    • Estradiol
    Denmark

  • Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Levofolinate
    • Cetuximab
    Italy Spain

  • Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Ireland +4

  • Study on Brain Imaging for Alzheimer’s Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer’s Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florquinitau (18F)
    Belgium

  • Study on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Bulgaria Denmark Estonia Lithuania Poland

  • Study on the Use of 18F-PI-2620 to Detect Alzheimer’s in People with Down Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    • Trisomy 21
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain
Previous Page
1 … 183 184 185 186 187 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!